Aim: To evaluate long-term clinical response to periodontal therapy and maintenance in localized aggressive periodontitis (LAP). Materials and Methods: One hundred forty-one African Americans diagnosed with LAP, aged 5-25 years, were enrolled. Patients underwent periodontal mechanical debridement plus 1 week of amoxicillin/metronidazole. Mechanical therapy was repeated as needed and clinical parameters were recorded at baseline, 3, 6, 12, 18 and 24 months, and two additional annual follow-up visits after treatment. Radiographs from primary dentition of patients with LAP in permanent dentition, and additional healthy siblings (HS) were analysed retrospectively. Results: Periodontal therapy significantly improved probing depth and clinical attachment level up to 4 years (mean reductions: 2.18 AE 1.03 and 2.80 AE 1.43 mm, respectively). Percentage of affected sites was reduced at all time points and maintained up to 4 years. Non-compliance with antibiotics/appointments negatively affected the treatment response. Ninety per cent of LAP patients in permanent dentition and 32% of HS presented radiographic bone loss in primary dentition. Conclusions: Mechanical debridement with 1 week of systemic antibiotics along with proper periodontal maintenance was effective in the treatment and successful maintenance of LAP for up to 4 years. LAP in permanent dentition may be preceded in the primary dentition. Clinicaltrials.gov #NCT01330719.
treatment of this disease with mechanical debridement alone (Saxen et al. 1986) , this regimen has resulted in certain limitations, especially regarding the control of invading and highly pathogenic microorganisms on oral tissues, such as the Aggregatibacter actinomycetemcomitans (Aa) (Meyer et al. 1996 , Christersson et al. 1985 , Xajigeorgiou et al. 2006 , Christersson & Zambon 1993 , Herbert et al. 2016 , Aberg et al. 2015 . Thus, the combination of mechanical treatment with adjunctive Abx has been suggested in the treatment of aggressive periodontitis in an attempt to successfully reduce pathogenic bacteria, especially Aa, which has been long and strongly associated with this disease (Darby & Curtis 2001) , including in the population studied here ). In addition, the elimination of putative periodontal pathogens is especially important in this population as aggressive periodontitis patients are also reported to present a hyperinflammatory response to bacterial LPS (Shapira et al. 1994 , Shaddox et al. 2010 . Finally, this combination treatment has also shown superior clinical results in previous systematic reviews (Sgolastra et al. 2012 , Rabelo et al. 2015 .
In the last decades, several studies have recognized that the amoxicillin/ metronidazole combination promotes better improvements in Aa levels/clinical parameters than scaling and root planing (SRP) alone or other antibiotics alone for aggressive periodontitis treatment, including LAP (van Winkelhoff et al. 1989 , Tinoco et al. 1998 , Winkel et al. 1998 , Guerrero et al. 2005 , Xajigeorgiou et al. 2006 , Griffiths et al. 2011 , Sgolastra et al. 2012 , Keestra et al. 2015 , Rabelo et al. 2015 . Such benefits of adjunctive amoxicillin/ metronidazole combination have also been demonstrated in LAP up to 1 year (Tinoco et al. 1998 , Beliveau et al. 2012 , Merchant et al. 2014 ) and up to 5 years on a smaller population (Aberg et al. 2015) . However, long-term benefits and clinical stability following this treatment and associated factors have not yet been evaluated in a large cohort of LAP.
Our group has been able to gather a large population of African Americans diagnosed with LAP and follow their treatment responses for 4 years, thus far. The aim of this study was to evaluate the long-term clinical response of these patients after full-mouth mechanical debridement (MD) with systemic antibiotics (Abx), and the impact of compliance with this drug regimen as well as with clinical appointments on this response. In addition, as previous studies have hypothesized that LAP may have its start in primary dentition, later progressing to permanent dentition (Baer 1971 , Cogen et al. 1992 , Albandar 2014 , we also aimed to retrospectively evaluate the past history of bone loss in primary dentition in LAP cases diagnosed on permanent dentition.
Materials and Methods

Participant population
This study is a longitudinal clinical trial of LAP in children, adolescents and young adults (ClinicalTrials.gov #NCT01330719). It comprised data of our previous report of 12 months follow-up in LAP cases (Merchant et al. 2014 ) with additional patients enrolled, presenting for at least two follow-up appointments after treatment, up to 4 years. In this investigation, 141 systemically healthy African Americans, aged 5-25 years, diagnosed with LAP, were recruited from December 2006 to 2014, from Leon County Health Department, Tallahassee, Florida, Duval County Health Department, Jacksonville, Florida and University of Florida, Gainesville, Florida. All data collected were obtained under the protocol approved by the Institutional Review Board at the University of Florida. All participants and their legal representative signed the approved informed consent to be included in this study.
Medical and dental histories were assessed for each individual. Inclusion criteria for the LAP population were as follows: systemically healthy, African-American patients diagnosed with LAP, as defined by at least two sites (incisor and/or first molar, in permanent or primary dentition), with probing depths (PD) ≥ 5 mm with bleeding on probing (BOP), concomitant clinical attachment level (CAL) ≥ 2 mm and radiographically detected bone loss (Armitage 1999 , Albandar 2014 . Exclusion factors were as follows: history of systemic disease with a potential to influence periodontal diseases (such as diabetes, neutropenia, acquired immunodeficiency syndrome, Down syndrome or hypophosphatasia); having taken antibiotics within the previous 3 months; smoking; pregnancy and lactation; diseased patients presenting allergy to penicillin. Patients were excluded during the trial if they no longer meet eligibility criteria, if they missed two consecutive time points or we were no longer able to contact for appointments.
Healthy siblings (HS) of LAP patients were included in the retrospective radiographic analysis and followed the same criteria as above, except for the presence of LAP, and were defined as healthy by the absence of bone loss and pockets >3 mm with concomitant CAL > 1 mm, and presenting permanent dentition only.
Clinical measurements
The following clinical parameters were assessed immediately prior to treatment initiation: PD, CAL, BOP and visible plaque. Gingival margin position (GMP) was measured as a negative number if the margin was coronal to the cementum-enamel junction. CAL was calculated by adding PD and GMP. Partially erupted teeth and third molars, if present, were not probed. Measurements were executed by calibrated examiners (LS, PH) with the use of a 15 mm periodontal probe (UNC-15, Hu-Friedy, Chicago, IL, USA) at 6 sites per tooth, rounded to the nearest millimetre and recorded with a periodontal software program (Florida Probe, Gainesville, FL, USA). Intra-and inter-examiners calibration was achieved when 80% of duplicate measures of PD and CAL were within 1 mm. All clinical parameters were recorded at baseline, immediately before treatment, and at 3, 6, 12, 18, 24 months, and additional two annual visits, following treatment.
Periodontal treatment
All LAP patients received supra/subgingival full-mouth debridement with an ultrasonic scaler (MD) (Cavitron JET Plus, Dentsply, York, PA, USA), followed by SRP with manual instruments in deeper pockets, as needed. Local anaesthesia was administered as needed. Immediately after MD/SRP at baseline, the patients were placed on 500 mg amoxicillin and 250 mg metronidazole three times a day for only 7 days (Buchmann et al. 2002 , Kaner et al. 2007 , Moreira & FeresFilho 2007 , in the attempt to minimize possible side effects and pocket re-colonization after the first week. Dosage adjustments were made for patients weighing less than 40 kg, according to the manufacturer instructions. Mechanical treatment was attempted to be completed at the baseline visit. If this was not possible (rare occurrence), the Abx were started at the second visit (within a week or 2), following another MD (to disrupt biofilm) and SRP completion.
Periodontal maintenance was performed with supra-subgingival MD and SRP on remaining pockets >4 mm, as needed, at all follow-up appointments. Oral hygiene instructions and oral hygiene kits were provided and reinforced to patients at all time points. A rigorous plaque control regiment and an electric toothbrush (Henry Schein, Melville, NY, USA) were also provided to each patient at baseline, along with appropriate instructions on its use, and extra brush heads and plaque control reinforcement were provided as needed at follow-up appointments.
Possible side effects from the medications were monitored via a written antibiotic log, and verbally with patients/parents. The medication bottles were checked for remaining pills at the first follow-up visit after treatment.
Patient compliance
Clinical treatment response of compliant versus non-compliant patients was evaluated, and compliance with both antibiotics and clinical appointments was analysed separately.
Patients were considered compliant with antibiotics (C-Abx) if they had taken over half of the pills from the bottles of both antibiotics. Patients who either did not take one or both the antibiotics or just up to half of one or both bottles of antibiotics were considered non-compliant with antibiotics (NC-Abx). They were also considered non-compliant if they had not taken the pills for 2 or more consecutive days. Compliance was checked with parent/guardian (in case they were minor) and with patient verbally, by a manual antibiotic log they filled out and by left over pill counting. Compliance was determined at the first time point following treatment and compliant and noncompliant groups were compared from baseline. In the group of NCAbx, if recurrence or non-response of the disease was noted, patient was then retreated with antibiotics. Thus, only the time points after "noncompliance" were analysed here as part of the "noncompliant group".
Patient appointment compliance was determined at each time point in the following way: patients were considered compliant only when they completed all time points (C-App) and considered non-compliant (NCApp) if they missed one or more time points between baseline and each of the time points, starting at 6 months. For instance, if a patient came to their baseline, 3-month and 6-month time points, they were considered compliant (C-App) at 6 months. Conversely, patients who missed the 3-month time point were considered non-compliant (NC-App) at 6 months. Similarly, analysis of clinical parameters at 12, 18 and 24 months, patients who completed all time points between the baseline and each of these time points were considered C-App, whereas patients who have missed one or more visits between the baseline and these time points were considered NC-App. Patients who had at least one follow-up appointment were considered for all analysis, and patients with no follow-ups were excluded from all analyses. In addition, number of missed appointments between baseline and 12 months and baseline and 24 months was also considered for correlations with clinical parameter reductions at these time points.
Retrospective radiographic analysis of primary dentition Dental records of all patients diagnosed with LAP in permanent dentitions at baseline were examined for presence of bone loss in bitewing radiographs from their primary dentition, when available. HS of LAP patients were also included in this analysis. Radiographs were searched for in the dental records of each patient and, when available, were collected by a separate author (NH). Only the primary dentition radiographs were then analysed for the presence of bone loss by two calibrated examiners (LS and KM), who were blinded to the current diagnosis of the patients.
Statistical analyses
Means of PD and CAL were calculated for sites with PD > 4 mm with concomitant CAL ≥ 2 mm (affected sites). The percentage of pockets with PD > 4 mm, deep sites (PD > 4 mm) with concomitant BOP (DB), affected sites, BOP and sites with visible plaque was also computed for each patient at each time point. Analyses of all clinical parameters before and after treatment were conducted for all patients by Kruskal-Wallis test with Dunn's multiple comparisons, which accounted for missing data. Compliant versus non-compliant patients were compared by Mann-Whitney test at the different time points. Spearman correlations were also run between number of visits made between baseline and 12 months, and between baseline and 24 months, and the reductions in clinical parameters at 12-and 24-month time points. Pearson/Spearman correlations were run between plaque levels and mean PD and CAL before and after treatment to evaluate influence of plaque control regimen and clinical response to treatment. In addition, multivariate analyses were performed for PD at 12 and 24 time points with dentition type included as a fixed factor and baseline PD and CAL as covariates to evaluate influence of dentition in the response to treatment at 12 and 24 months. All statistical analyses were performed using SPSS and the GraphPad Prism v.5.0 software (GraphPad Software, La Jolla, CA, USA).
Results
Participants
Of the 141 LAP subjects initially enrolled, 124 were included in the 4-year period analyses. Seventeen patients were excluded from the overall analysis due to lack of follow-up appointments (N = 11 patients) or ineligibility (N = 6 patients) (see supplement flowchart). Other patients were lost during follow-up (unable to contact for follow-up or became ineligible) or simply missed a time point but were still in the trial. Flowchart present final N of available time points analysed. Table 1 presents a summary of the demographics of the LAP population enrolled in the study, as well as their clinical parameters at baseline. This LAP population comprised of 27 patients presenting mixed dentition, where only primary dentition was affected and 97 patients with permanent dentition affected. No patients had both dentitions affected simultaneously. Most teeth affected in permanent dentition were first molars and incisors, although few patients presented only first molars or only incisors affected. Most teeth affected in primary dentition were first molars, although second molar involvement was a frequent finding in more severe cases.
Four patients were submitted to surgical procedure after initial nonsurgical therapy was completed. Four extractions were performed in a total of three patients. No side effects to the prescribed antibiotic regimen were reported. Only a few patients commented on the "bad taste" of metronidazole, but none interrupted intake for that reason. NC-Abx patients usually just reported having "forgotten" to take the medication. Nineteen HS of both genders (11 females and 8 males) aged 10-17 years (12.37 AE 1.87) were included in the retrospective radiographic analyses.
Clinical treatment response
In this study, periodontal treatment resulted in improvement of clinical parameters up to 4 years. The statistical analyses demonstrated an overall significant reduction in mean PD, mean CAL, percentage of deep and bleeding (DB, PD > 4 mm and concomitant BOP) and percentage of affected sites (%LAP diseased sites) from the baseline to all time points after therapy (p < 0.0001 or p < 0.001; Fig. 1A-D, respectively) . Percentage of BOP significantly decreased from the baseline to 3 (p < 0.01), 6 (p < 0.05) and 12 months (p < 0.001, Fig. 1E ). Percentage of plaque significantly decreased from baseline to 3 (p < 0.001), 6 (p < 0.01) and to 24 months (p < 0.05; Fig. 1F ). Figure 2 shows higher mean percentage of sites presenting PD/CAL gain (>1 mm) versus no gain/ increase at each time point, which were all significant (p < 0.0001; Fig. 2A,B, respectively) . About 50 to slightly above 60% of sites presented reductions in PD ≥ 2 mm and CAL ≥ 2 mm at all time points (p < 0.0001 and p < 0.001, respectively, Fig. 2C,D) . Table 2 shows that over 60% of patients presented over 50% reduction in affected sites (PD > 4 mm and CAL ≥ 2 mm) 3 months after treatment and this percentage continuously increased up to 100% at final follow-up.
Patient compliance
Baseline demographic and clinical parameters of all patients are shown in Table 1 and the ones evaluated in the compliance analyses are shown in Table S1 . No differences were found for any of the clinical parameters at baseline between the compliant and non-compliant groups (p < 0.05). Regarding the compliance with antibiotics, data from 10 patients who were NC-Abx were compared with C-Abx (N = 114) up to 12 months after treatment. The reason for non-compliance with antibiotics for all 10 patients was reported as "forgetfulness". Although the number of NC-Abx was small, the percentage of PD reduction in C-Abx patients was higher than NC-Abx at 3 (p < 0.001), 6 (p < 0.01) and 12 months (p < 0.05, Fig. 3A) . The percentage of CAL reduction was also significantly higher in C-Abx than NC-Abx patients at 3 months (p < 0.01, Fig. 3B ).
Regarding patient compliance with clinical appointments, different time points were missed for different patients and mostly due to inability to make the appointment by the patient for different reasons: no reason given (simply no show), forgetfulness, school activities, car trouble and sickness in the family were the most common reasons reported by them. Although correlations were not significant between number of missed appointments and clinical parameter reductions at 12 and 24 months (p > 0.05), C-App showed lower mean values than NC-App for mean PD and %DB at 6 months (p < 0.001 and p < 0.01, respectively) and lower mean CAL at 18 months (p < 0.05). No significant differences were found between C-App and NC-App at the remaining time points (p > 0.05).
Representative photographs and radiographs of compliant LAP patients at baseline and after periodontal therapy are shown in Fig. 4 .
Baseline plaque levels were statistically but weakly positively correlated with baseline levels of CAL (p = 0.037 and r = 0.185) but not with PD (p = 0.083, r = À0.154). However, post-treatment levels of plaque were not correlated with post-treatment mean PD and CAL, at any time point (p > 0.05).
In addition, multivariate analysis showed that both dentitions presented significant reductions in PD and CAL over time. Dentition also significantly influenced response to treatment in terms of mean PD and CAL, after correcting for baseline PD and CAL, at 12 and 24 months post-treatment (p < 0.05). Here, primary dentition patients presented with lower levels of mean PD and mean CAL at 12 and 24 months post-treatment compared to permanent dentition (p < 0.05) ( Table 2) .
Retrospective radiographic analyses
We were able to gather primary dentition radiographs of 20 patients diagnosed with LAP in permanent dentition at baseline, and 19 HS with permanent dentition at baseline. Three HS later developed LAP disease during the study. Eighteen LAP patients (90%) were found to present moderate-to-severe bone loss around their first and second primary molars, retrospectively. In the HS group, six (32%) patients presented bone loss in the primary dentition, of which two developed the disease at a later time point in the study in their permanent dentition. Clinical photographs and/or radiographs of both primary and permanent dentitions of patients diagnosed with LAP in the permanent dentition are presented in Fig. 5 . In addition, Fig. 5 shows radiographs of both primary and permanent dentitions of one representative HS; this last patient presented progressing bone loss in the primary dentition, although no disease was observed in the permanent dentition thus far ( Fig. 5C-E) .
Discussion
To the best of our knowledge, this investigation is the first long-term evaluation of clinical treatment response of a large LAP cohort, as well as associated factors that may contribute to such response. It was demonstrated here that the vast majority of LAP patients were successfully treated with non-surgical mechanical debridement and a one course of systemic antibiotic therapy and that compliance with both antibiotics and appointments was important.
This conservative approach in association with periodontal maintenance provided significant and continuous improvement of clinical parameters and long-term clinical stability (up to 4 years). Furthermore, the present evidence of radiographic alveolar bone loss in the primary dentition of most LAP patients investigated here suggest that this disease may indeed start in primary dentition and thus early diagnosis, in addition to this treatment approach, are important tools to control LAP disease. Interestingly, an established protocol and the prescription of a specific antibiotic regimen for LAP treatment has not yet been determined in the literature (Teughels et al. 2014 , Keestra et al. 2015 . As the disorganization/reduction in the subgingival biofilm is a prerequisite for greater efficiency of antimicrobials, mechanical debridement before antibiotic administration has been recommended (Kaner et al. 2007 , Sedlacek & Walker 2007 , Griffiths et al. 2011 ). In aggressive periodontitis, including LAP, administration of antibiotics immediately after the mechanical debridement has resulted in greater reductions in PD and CAL compared with SRP alone or the administration of antibiotics at a later time after initial therapy, along with maintenance (Kaner et al. 2007 , Beliveau et al. 2012 , Sgolastra et al. 2012 , Keestra et al. 2015 , Rabelo et al. 2015 . Thus, the protocol of choice in this study was the prescription of combination of adjunct amoxicillin/metronidazole immediately following full-mouth mechanical debridement. Although some studies have used a variety of different timing of antibiotics, starting before, during or after mechanical therapy, there is unfortunately no good evidence of what is the most beneficial dosage or timing of these agents (Haffajee et al. 2003 , Haffajee 2006 ). We also decided on a shorter duration of the antibiotic regimen (7-day course rather than a 14-day course) to avoid possible side effects and antibiotic activity on possible new biofilm re-formation after the first week (Harper & Robinson 1987 , Quirynen et al. 2005 , which would have reduced its effectiveness, as shown previously (Sedlacek & Walker 2007) . In rare occasions in this study, the antibiotics were prescribed on a second session to enable mechanical debridement completion (rare occurrence as most cases had very little calculus and the disease was localized to very few teeth/sites in the mouth). However, antibiotic prescription was always preceded by another full-mouth calculus removal/biofilm disruption to maximize its effectiveness.
Few long-term studies using this treatment approach had been performed in LAP, and existing studies were performed in small populations (Tinoco et al. 1998 , Bimstein 2003 , possibly due to the low prevalence of LAP. In this study, significant reductions in the clinical parameters could be observed in the short-term following therapy (3 months) and were well maintained/improved up to 4 years during maintenance, which is in agreement with previous reports on the long-term treatment/ maintenance of a group of generalized aggressive periodontitis (GAP) with similar antibiotic regimen, despite patients receiving surgical treatment at baseline (Buchmann et al. 2002) . The magnitude of PD reduction and CAL gain (or % sites with reduction/gain) is also similar or superior to those reported in previous studies on LAP (Tinoco et al. 1998) , and on GAP (Varela et al. 2011) , although the later study used surgery in combination with systemic similar regimen of antibiotics (Varela et al. 2011) . Furthermore, we often observed radiographic bone fill of diseased sites after treatment, which has been previously reported in a 1 year follow-up of 25 LAP patients (Tinoco et al. 1998) as well as in a 7-year follow-up study (Bimstein 2003) , using similar treatments. However, further studies need to be properly conducted to confirm bone fill observed here. Very few surgeries (only four patients) were performed and very few teeth were lost (only four extractions). These do not count primary affected teeth that exfoliated. This little loss in this study (0.007 per patient-year) is lower than reported in a systematic review for LAP patients (0.05 per patient-year) (Nibali et al. 2013 ). However, we should note that the three LAP studies included in this later review used different treatment modalities and maintenance protocols compared to this investigation. Altogether, our clinical data in a large cohort of LAP patients showed the efficacy of mechanical debridement combined with a one-time regimen of amoxicillin/metronidazole, and that long-term clinical stability of periodontal parameters could be attained. Interestingly, plaque control was not correlated with post-treatment outcomes here. To the best of our knowledge, plaque control has been evaluated with aggressive disease recurrence in only one previous study, which was conducted on a mixed population of GAP and LAP (where only a few patients received antibiotics), with non-controlled compliance, and baseline plaque levels on both groups was different between treated and untreated patients, making it difficult to assess whether this parameter was really a factor in the recurrence/progression of disease (Gunsolley et al. 1995) . However, this study does show that compliance with appointments, where professional plaque removal was performed, influenced treatment outcomes, as discussed below. It is also important to note that this study was not properly designed to evaluate the specific effects of plaque control on LAP response to treatment and thus plaque control should still be regarded an essential part of treatment and its role in LAP treatment response needs to be further investigated.
Another interesting data reported here is the fact that no patients presented an increase in the number of affected sites after treatment at any time point (no progression), and that the vast majority of patients actually showed >50% reduction in the percentage of sites with disease (~60% at 3 months then up to 100% at last follow-up), which shows the gradual improvement of the disease with time. Whether this is a result of the initial adjunct antibiotic use or proper maintenance is yet to be evaluated.
The one-time adjunctive use of antibiotics, with no reported side effects, as shown previously by others (Muller et al. 1998 , Baltacioglu et al. 2011 , Rodrigues et al. 2012 , as well as the stability of the clinical results in the long-term in this study, supports the notion that this treatment protocol is clinically effective for the treatment of LAP, despite the lack of a comparison with other treatment approaches and the evaluation of antibiotic resistance, which should still be performed.
Previous studies on antibiotic resistance show that a one-course systemic antibiotic use adjunct to mechanical debridement have resulted in transient bacterial resistance, which decreased shortly after cessation of antibiotic intake (Fiehn & Westergaard 1990 , Feres et al. 1999 , Haffajee 2006 . Nonetheless, proper evaluation of bacterial resistance needs to be further investigated, as well as the comparison with a control group receiving SRP only to derive proper conclusions as to the best treatment approach for these patients.
Another controversial topic is whether to perform a microbial analysis prior to selection of an antibiotic regimen. Due to existing literature, we assume because this is aggressive periodontitis, that Aa is most likely present and that a combination of amoxicillin/metronidazole would be effective, as previously investigated (van Winkelhoff et al. 1989 , Rabelo et al. 2015 . In fact, a prior study from our group found strong presence of this species along with other periopathogens in this LAP population . However, elimination of Aa was not the only reason we opted for this regimen. We found this treatment protocol to work better than SRP alone for the initial patients treated on this trial (Beliveau et al. 2012 ), in agreement with other studies (Keestra et al. 2015 and Rabelo et al. 2015) . In fact, a recent study has found that the use of adjunct antibiotics resulted in better clinical response than SRP alone independent of the presence of Aa (Mombelli et al. 2013) . These reasons coupled with the fact that these patients do possess a hyperinflammatory response to bacterial LPS (Shapira et al. 1994 , Shaddox et al. 2010 led us to the choice of adjunctive antibiotics here. Although proper evidence is still needed to support a microbial diagnosis prior to treatment selection, there are still good reasons to do it and to continue to prescribe antibiotics with caution, especially to avoid possible bacterial resistance (Haffajee 2006 , Shaddox & Walker 2009 ).
In addition, we observed that compliance with antibiotics led to a greater reduction in the percentage of PD up to 12 months and CAL reduction in the short term (3 months). However, we only had a few participants in the non-compliant group and, thus, these results need to be confirmed by larger cohort studies with that specific purpose. Our results are, nonetheless, in agreement with a previous pilot study on GAP showing that compliance with antibiotics was also important to attain better clinical parameters (Guerrero et al. 2007 ). Furthermore, although we expected a stronger impact of patient appointment compliance on the clinical results, we observed that C-App presented lower PD and CAL levels when compared to NC-App. However, it was also observed that all patients continued to maintain/ improve their clinical parameters, regardless of their appointment compliance. Similar results were reported in a 19-year follow-up of 11 children treated for LAP (Mros & Berglundh 2010) , where most patients did not display recurrence of the disease even in the absence of periodontal maintenance. Thus, more studies on the mechanisms of LAP progression and treatment responses, including the influence of the host immuneinflammatory response and patient compliance, need to be performed to better elucidate individual long-term responses to treatment.
Results of our retrospective radiographic analyses suggest that LAP may start as early as in primary dentition, as the vast majority of patients with LAP in the permanent dentition here also presented radiographic bone loss in the primary dentition. Similarly to our findings, Cogen et al. (1992) presented data from a retrospective radiographic analysis of 4,757 subjects, which included 52 LAP cases. In this later study, a total of 14 mixed and 7 primary dentition radiographs of these subjects were analysed retrospectively, and 12 patients were found to have bone loss in the mixed dentition (85.7%) and 5 in the primary dentition (71.4%). Sjodin et al. (1989) also observed the vast majority (16 of 17) of patients with LAP in permanent dentition presented marginal bone loss in the primary dentition. As only a few cases did not show bone loss in primary radiographs in these studies, including only two on this study, it is possible that the disease had not yet initiated at the time radiographs in the primary dentition were evaluated/available. Thus, these previous studies coupled with our present results lead us to believe that LAP may indeed start early, in the primary dentition, and its treatment at early stages may prevent the progression of disease in permanent dentition, as suggested previously (Bimstein 2003 , Merchant et al. 2014 .
Noteworthy, one-third of the HS of LAP patients analysed here showed signs of LAP disease in primary dentition as well. Of these, three further developed the disease during this study, two of which showed signs of bone loss in the primary dentition. This result along with previous literature showing family aggregation of this disease (Bimstein et al. 1997 , Bimstein 2003 , Meng et al. 2011 suggests that families should be monitored for early detection/treatment of LAP. In fact, we previously showed that HS of LAP individuals have an attenuated (compared to LAP), yet high (compared to unrelated controls), inflammatory response to lipopolysaccharide (Shaddox et al. 2010) , which could indicate these HS may have an underlying susceptibility to LAP. Further studies need to be conducted in the attempt to associate inflammatory response levels with prior history of disease in primary dentitions and actual development of LAP in permanent dentition. Currently in our cohort, this evaluation is not possible as we only have very few siblings who actually developed LAP during our follow-ups, which makes us further believe this disease may indeed be prevented with strict periodontal maintenance.
Important to note that this study did not evaluate the effectiveness of this treatment regimen against SRP alone. Thus, we cannot conclude that this treatment approach is superior to SRP alone or any other regimen in the long term. Other studies have evaluated the comparison of adjunctive antibiotic treatment versus SRP alone, as mentioned above (Keestra et al. 2015) . This investigation also did not evaluate the results of this treatment on the microbial flora or on bacterial resistance. Other studies have attempted to evaluate that with different regimens, as mentioned above (Fiehn & Westergaard 1990 , Feres et al. 1999 . We can only conclude here that the treatment approach used in this study, which consisted of a fullmouth supra/subgingival debridement along with a one-time 7-day course of amoxicillin and metronidazole and proper maintenance, was effective in reducing clinical parameters of affected sites in this population with LAP at 3 months post-treatment, and that these results were maintained for 4 years. We can also conclude that the 'gross' noncompliance with antibiotics and visits slightly and negatively affected these results. Finally, the majority of patients diagnosed with LAP in the permanent dentition, who were analysed retrospectively, also presented radiographic bone loss in their primary dentition, which may suggest an early initiation for this disease. Further studies need to be conducted to compare different treatments approaches for LAP, properly designed to better evaluate the additional risk factors mentioned above.
Supporting Information
Additional Supporting Information may be found in the online version of this article: Figure S1 . Flowchart. This flowchart shows numbers of patients in the trial, drop-outs and number of each available time point for each analysis performed, including compliance analysis. Note the number (N) of time points does not necessarily mean number of patients in the trial, as patients still in the trial may have missed one or more time point(s) or still be in follow up, as this is an ongoing study. Compliance with appointments was defined at each time point: a patient was considered compliant if they completed all time points between baseline and each time point analysed. Drop-out reasons vary but the vast majority were due to inability to contact the patient for follow-ups (n = 29), followed by non-compliance with appointments (missed two consecutive time points, n = 13), patient becoming ineligible during trial (n = 7, five became pregnant, one was later diagnosed with lupus and one went to prison) and patient withdrew due to lack of interest to continue participation (n = 6). Table S1 . Baseline values of antibiotic and appointment compliant and non-compliant groups. Table S2 . Statistical comparison of clinical parameters before and after treatment between LAP affected permanent and primary dentition individuals.
